Agilent Technologies, Inc.

A Healthcare Diagnostics & Research

Agilent Technologies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $6.9 billion, up 6.73% from fiscal 2024. In the quarter to July 2026, revenue grew 8.06%, EPS grew 8.47%, free cash flow grew 69.5% and total debt rose 8.81%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years.

172.96 2.59 −1.48%
Market cap
$49.5B
P/E
34.0×
Fwd P/E
26.3×
Dividend yield
0.59%
F-score
5/9
Altman Z
5.46
Beneish M
−2.46
Dividend safety
86/100

Agilent Technologies, Inc. (A) Operating cash flow

Alert me on Operating cash flow

Agilent Technologies, Inc.'s operating cash flow for fiscal 2025 was $1.6B, down 11.0% from $1.8B in fiscal 2024. Over the twelve months to 31 July 2026 it was $1.6B. Over the past ten years it has ranged from $512.0M (fiscal 2015) to $1.8B (fiscal 2023); the current reading is higher than 82% of that period. Agilent Technologies, Inc. ranks 6th of 52 Diagnostics & Research companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $1.6B (10.97%)
FY2024 $1.8B (1.19%)
FY2023 $1.8B 35.06%
FY2022 $1.3B (11.65%)
FY2021 $1.5B 61.24%
FY2020 $921.0M (9.79%)
FY2019 $1.0B (6.07%)
FY2018 $1.1B 22.27%
FY2017 $889.0M 12.11%
FY2016 $793.0M 54.88%

Quarterly newest first

Period Operating cash flow Change
Jul 2026 $519.0M 87.36%
Apr 2026 $277.0M 3.36%
Jan 2026 $268.0M (50.83%)
Oct 2025 $545.0M 50.55%
43 more quarters

Against its own ten years

Low $512.0M High $1.8B
Ten-year median $1.1B
Current reading's percentile 82

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on A